BALL KRISTINE M bought ELVN
October 14, 2026 · Form 4 insider transaction
BALL KRISTINE M bought 23,394 shares of Enliven Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
23,394
Price
$0.00
Total value
N/A
InsiderBALL KRISTINE M
RoleDirector
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateOctober 14, 2026
Filing dateOctober 16, 2026
Shares owned after23,394
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
1/36th of the shares subject to the option will vest on November 14, 2026 and each month thereafter, subject to the Reporting Person continuing as an outside director through each such date.